Lenihan DJ et al. |
Involvement of platelet activating factor in physiological stress in the lizard, Anolis carolinensis. |
1985 |
Comp. Biochem. Physiol. C, Comp. Pharmacol. Toxicol. |
pmid:2861063
|
Braquet P et al. |
Involvement of platelet activating factor in respiratory anaphylaxis, demonstrated by PAF-acether inhibitor BN 52021. |
1985 |
Lancet |
pmid:2861423
|
McIntyre TM et al. |
Cultured endothelial cells synthesize both platelet-activating factor and prostacyclin in response to histamine, bradykinin, and adenosine triphosphate. |
1985 |
J. Clin. Invest. |
pmid:2862164
|
Archer CB et al. |
Effects of serum albumin, indomethacin and histamine H1-antagonists on Paf-acether-induced inflammatory responses in the skin of experimental animals and man. |
1985 |
Br. J. Pharmacol. |
pmid:2862936
|
Morris HG |
Mechanisms of glucocorticoid action in pulmonary disease. |
1985 |
Chest |
pmid:2410202
|
Bruynzeel PL et al. |
Exclusive leukotriene C4 synthesis by purified human eosinophils induced by opsonized zymosan. |
1985 |
FEBS Lett. |
pmid:2995125
|
Doebber TW et al. |
Platelet activating factor (PAF) involvement in endotoxin-induced hypotension in rats. Studies with PAF-receptor antagonist kadsurenone. |
1985 |
Biochem. Biophys. Res. Commun. |
pmid:2985058
|
Bourgain RH et al. |
The effect of 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine (paf-acether) on the arterial wall. |
1985 |
Prostaglandins |
pmid:3931178
|
Ribbes G et al. |
Evidence that biosynthesis of platelet-activating factor (paf-acether) by human neutrophils occurs in an intracellular membrane. |
1985 |
FEBS Lett. |
pmid:3932094
|
GarcÃa-Sáinz JA and Hernández-Sotomayor SM |
Stimulation of hepatic glycogenolysis by 12-O-tetradecanoyl-phorbol-13-acetate (TPA) via cyclooxygenase products. |
1985 |
Biochem. Biophys. Res. Commun. |
pmid:3933497
|
Barnes PJ |
Mediators and asthma. |
1985 |
Br J Hosp Med |
pmid:3936563
|
Hemmendinger S et al. |
[Physiology of the interactions of blood and the blood vessel wall. Role of pharmacologically active lipids]. |
1985 |
Arch Mal Coeur Vaiss |
pmid:3938941
|
Iñarrea P et al. |
Synthesis of PAF-acether and blood volume changes in gram-negative sepsis. |
1985 |
Immunopharmacology |
pmid:3886598
|
Lellouch-Tubiana A et al. |
Ultrastructural evidence for extravascular platelet recruitment in the lung upon intravenous injection of platelet-activating factor (PAF-acether) to guinea-pigs. |
1985 |
Br J Exp Pathol |
pmid:3890915
|
Maes L et al. |
In vivo arterial platelet-vessel wall interaction and thrombosis: induction, on-line registration and ultrastructural control. |
1985 |
Adv. Exp. Med. Biol. |
pmid:3832867
|
Tuffin DP et al. |
Specific binding of [3H]-1-O-octadecyl Paf-acether to washed human platelets. |
1985 |
Adv. Exp. Med. Biol. |
pmid:3834789
|
Inoue K et al. |
Activation of guinea pig peritoneal macrophages by platelet-activating factor in free form or incorporated into liposomes. |
1985 |
Adv. Prostaglandin Thromboxane Leukot. Res. |
pmid:2936203
|
Parente L and Flower RJ |
Hydrocortisone and 'macrocortin' inhibit the zymosan-induced release of lyso-PAF from rat peritoneal leucocytes. |
1985 |
Life Sci. |
pmid:3838566
|
Tokumura A and Tsukatani H |
[Antagonists of platelet activating factor]. |
1985 |
Seikagaku |
pmid:3009656
|
MacIntyre DE et al. |
Agonist-induced inositol phospholipid metabolism and Ca++ flux in human platelet activation. |
1985 |
Adv. Exp. Med. Biol. |
pmid:3010662
|
Teng CM et al. |
Action mechanism of the platelet aggregation inducer and inhibitor from Echis carinatus snake venom. |
1985 |
Biochim. Biophys. Acta |
pmid:3926005
|
Ostermann G et al. |
Platelet-stimulating and membranolytic properties of racemic PAF-acether and analogues. |
1985 |
Biomed. Biochim. Acta |
pmid:4004829
|
Touqui L et al. |
Human platelets stimulated by thrombin produce platelet-activating factor (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) when the degrading enzyme acetyl hydrolase is blocked. |
1985 |
Biochem. J. |
pmid:4052028
|
Satouchi K et al. |
Evidence for production of 1-acyl-2-acetyl-sn-glyceryl-3-phosphorylcholine concomitantly with platelet-activating factor. |
1985 |
Biochem. Biophys. Res. Commun. |
pmid:4004866
|
Benveniste J |
Paf-acether (platelet-activating factor). |
1985 |
Adv. Prostaglandin Thromboxane Leukot. Res. |
pmid:3159192
|
Detsouli A et al. |
Histamine and leukotriene-independent guinea-pig anaphylactic shock unaccounted for by Paf-acether. |
1985 |
Br. J. Pharmacol. |
pmid:4005486
|
Korth R et al. |
Unsaturated 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholines (unsaturated platelet-activating factor): aggregation of human platelets after incubation with indomethacin, creatinephosphate/creatinephosphokinase, xylocain and hirudine, and serotonin release after incubation with indomethacin. |
1985 |
Chem. Phys. Lipids |
pmid:4006034
|
Verstraete M et al. |
An overview of antiplatelet and antithrombotic drugs. |
1985 |
Haemostasis |
pmid:3159632
|
Apprill P et al. |
Cyclic blood flow variations induced by platelet-activating factor in stenosed canine coronary arteries despite inhibition of thromboxane synthetase, serotonin receptors, and alpha-adrenergic receptors. |
1985 |
Circulation |
pmid:2988822
|
Benveniste J and Chignard M |
A role for PAF-acether (platelet-activating factor) in platelet-dependent vascular diseases? |
1985 |
Circulation |
pmid:3928192
|
Ogunbiyi PO and Eyre P |
Pharmacological studies of pulmonary anaphylaxis in vitro: a review. |
1985 |
Agents Actions |
pmid:2420161
|
Kozlov VK et al. |
[Characteristics of the activation of rabbit platelets induced by 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine (platelet activation factor)]. |
1985 |
Biull Eksp Biol Med |
pmid:4052603
|
Page CP et al. |
Properties of PAF-acether appropriate to a mediator of the inflammatory aspects of asthma. |
1985 |
Int J Tissue React |
pmid:4055261
|
Wardlow ML |
Rapid isocratic procedure for the separation of platelet-activating factor from phospholipids in human saliva by high-performance liquid chromatography. |
1985 |
J. Chromatogr. |
pmid:4055961
|
Hubbard JW et al. |
Cardiac output and peripheral vascular resistance during intravenous infusion of 1-hexadecyl-2-acetyl-sn-glycero-3-phosphocholine in conscious normotensive and spontaneously hypertensive rats. |
1985 |
Res. Commun. Chem. Pathol. Pharmacol. |
pmid:4059660
|
Imbs AB et al. |
[Synthesis of a fluorescently-labeled platelet activating factor]. |
1985 |
Bioorg. Khim. |
pmid:4062993
|
Tokumura A et al. |
Gas chromatographic-mass spectrometric analysis of biologically active phospholipids having an sn-2-acetyl group. |
1985 |
J. Chromatogr. |
pmid:4066848
|
Meloni Bruneri LH and Barbieri D |
[Platelet aggregation after the reduction of nitro-blue tetrazolium by eosinophils]. |
1985 |
Sangre (Barc) |
pmid:4071355
|
Söling HD et al. |
Regulation of protein kinases in exocrine secretory cells during agonist-induced exocytosis. |
1985 |
Adv. Enzyme Regul. |
pmid:4072796
|
Vanhoutte PM and Houston DS |
Platelets, endothelium, and vasospasm. |
1985 |
Circulation |
pmid:3861273
|
Weisman SM et al. |
Platelet-activating factor is a potent stimulus for renal prostaglandin synthesis: possible significance in unilateral ureteral obstruction. |
1985 |
J. Pharmacol. Exp. Ther. |
pmid:3862805
|
Morley J et al. |
PAF and airway hyperreactivity. |
1985 |
Lancet |
pmid:2863479
|
Morley J et al. |
Platelets in asthma. |
1985 |
Lancet |
pmid:2863708
|
Cox CP |
Activation of washed chicken thrombocytes by 1-O-hexadecyl/octadecyl-2-acetyl-sn-glycero-3-phosphorylcholine (platelet-activating factor). |
1985 |
Comp Biochem Physiol A Comp Physiol |
pmid:2864195
|
Snyder F |
Chemical and biochemical aspects of platelet activating factor: a novel class of acetylated ether-linked choline-phospholipids. |
1985 Jan-Mar |
Med Res Rev |
pmid:2984489
|
Kozubski W and Stańczyk L |
[Platelet aggregation in patients with migraine during the pain attack and in the pain-free period]. |
1985 Jul-Aug |
Neurol. Neurochir. Pol. |
pmid:4094642
|
Bette-Bobillo P et al. |
Synthesis and characterization of a radioiodinated, photoreactive and physiologically active analogue of platelet activating factor. |
1985 Jun-Jul |
Chem. Phys. Lipids |
pmid:4042252
|
Leprán I and Lefer AM |
Ischemia aggravating effects of platelet-activating factor in acute myocardial ischemia. |
1985 Mar-Apr |
Basic Res. Cardiol. |
pmid:4039929
|
Feuerstein G et al. |
Thyrotropin-releasing hormone blocks the hypotensive effects of platelet-activating factor in the unanesthetized guinea pig. |
1985 Mar-Apr |
J. Cardiovasc. Pharmacol. |
pmid:2581089
|
Mencia-Huerta JM |
Possible role of the T-cell-factor-dependent mast cell subclass in the generation of leukotrienes from lung. |
1985 Sep-Oct |
Ann. Inst. Pasteur Immunol. |
pmid:3878684
|
Masugi F et al. |
Role of acetyl glyceryl ether phosphorylcholine in blood pressure regulation in rats. |
1985 Sep-Oct |
Hypertension |
pmid:4030044
|
Prunieras M |
Melanocytes, melanogenesis, and inflammation. |
1986 |
Int. J. Dermatol. |
pmid:2433237
|
Moudgil GC |
Anaesthesia and allergic drug reactions. |
1986 |
Can Anaesth Soc J |
pmid:3521800
|
Foegh ML et al. |
Prolongation of cardiac allograft survival with BN 52021, a specific antagonist of platelet-activating factor. |
1986 |
Transplantation |
pmid:3523888
|
Kertscher HP and Ostermann G |
[Synthesis and thrombocyte aggregating action of stereoisomers of PAF-acether]. |
1986 |
Pharmazie |
pmid:3786385
|
Rampart M and Williams TJ |
Polymorphonuclear leukocyte-dependent plasma leakage in the rabbit skin is enhanced or inhibited by prostacyclin, depending on the route of administration. |
1986 |
Am. J. Pathol. |
pmid:3524253
|
Powling MJ and Hardisty RM |
Differential effects of 12-O-tetradecanoylphorbol 13-acetate on platelet responses to various agonists in the presence and absence of extracellular Ca2+. |
1986 |
Thromb. Res. |
pmid:3787566
|
Siffert W et al. |
Inhibition of platelet aggregation by amiloride. |
1986 |
Thromb. Res. |
pmid:3787567
|
Whittle BJ et al. |
Microvascular actions of platelet-activating factor on rat gastric mucosa and submucosa. |
1986 |
Am. J. Physiol. |
pmid:3789144
|
Suemune H et al. |
Enzymatic synthesis of 2,3-O-isopropylidene-sn-glycerol, a chiral building block for platelet-activating factor. |
1986 |
Chem. Pharm. Bull. |
pmid:3791517
|
Wardlaw AJ et al. |
Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils. |
1986 |
J. Clin. Invest. |
pmid:3023451
|
O'Flaherty JT et al. |
Metabolism of 5-hydroxyicosatetraenoate by human neutrophils: production of a novel omega-oxidized derivative. |
1986 |
J. Immunol. |
pmid:3095426
|
Pfueller SL and David R |
Different platelet specificities of heparin-dependent platelet aggregating factors in heparin-associated immune thrombocytopenia. |
1986 |
Br. J. Haematol. |
pmid:3756098
|
Hoffman DR et al. |
Cytotoxicity and metabolism of alkyl phospholipid analogues in neoplastic cells. |
1986 |
Cancer Res. |
pmid:3756924
|
Sage SO and Rink TJ |
Effects of ionic substitution on [Ca2+]i rises evoked by thrombin and PAF in human platelets. |
1986 |
Eur. J. Pharmacol. |
pmid:3758190
|
Chignard M et al. |
Use of steroidal antiinflammatory drug provides further evidence for a potential role of PAF-acether in bronchial anaphylaxis. |
1986 |
Int. Arch. Allergy Appl. Immunol. |
pmid:3759260
|
Roubin R et al. |
Biosynthesis of paf-acether: VIII: Impairment of paf-acether production in activated macrophages does not depend upon acetyltransferase activity. |
1986 |
J. Immunol. |
pmid:3950403
|
Ohno M et al. |
Molecular design toward biologically significant compounds based on platelet activating factor: a highly selective agonist as a potential antihypertensive agent. |
1986 |
J. Med. Chem. |
pmid:3761300
|
Parnham MJ and Bittner C |
Pharmacological analysis of guinea-pig macrophage chemiluminescence responses to platelet activating factor and opsonized zymosan. |
1986 |
Int. J. Immunopharmacol. |
pmid:3804536
|
D'Humières S et al. |
PAF-acether-induced synthesis of prostacyclin by human endothelial cells. |
1986 |
Eur. J. Pharmacol. |
pmid:3102256
|
Chung KF et al. |
Airway hyperresponsiveness induced by platelet-activating factor: role of thromboxane generation. |
1986 |
J. Pharmacol. Exp. Ther. |
pmid:3005546
|
Becker EL et al. |
Pertussis toxin as a probe of neutrophil activation. |
1986 |
Fed. Proc. |
pmid:3011523
|
Ozaki Y et al. |
Oxygen radical production by neutrophils from patients with bacterial infection and rheumatoid arthritis. Measurement of hydrogen peroxide may most accurately represent enhancement of oxygen radical production during infection. |
1986 |
Inflammation |
pmid:3011666
|
Schlondorff D et al. |
Different concentrations of pertussis toxin have opposite effects on agonist-induced PGE2 formation in mesangial cells. |
1986 |
Biochem. Biophys. Res. Commun. |
pmid:3099783
|
Doebber TW et al. |
Platelet-activating factor (PAF) mediation of rat anaphylactic responses to soluble immune complexes. Studies with PAF receptor antagonist L-652,731. |
1986 |
J. Immunol. |
pmid:3011900
|
Okayasu T et al. |
Metabolism of platelet-activating factor in primary cultured adult rat hepatocytes by a new pathway involving phospholipase C and alkyl monooxygenase. |
1986 |
Biochim. Biophys. Acta |
pmid:3947669
|
Tokumura A et al. |
Alkylacetylglycerophosphocholine effects on the metabolism of phospholipids in rabbit platelets: effects of extracellular Ca2+ and prostacyclin. |
1986 |
Arch. Biochem. Biophys. |
pmid:3013094
|
Baranes J et al. |
The effects of PAF-acether on the cardiovascular system and their inhibition by a new highly specific PAF-acether receptor antagonist BN 52021. |
1986 |
Pharmacol Res Commun |
pmid:3763677
|
Cirino M et al. |
A study with BN 52021 demonstrates the involvement of PAF-acether in IgE-dependent anaphylactic bronchoconstriction. |
1986 |
Prostaglandins |
pmid:3763941
|
Wallace JL and Whittle BJ |
Profile of gastrointestinal damage induced by platelet-activating factor. |
1986 |
Prostaglandins |
pmid:3763942
|
Bourgain RH et al. |
Thrombus induction by endogenic paf-acether and its inhibition by Ginkgo Biloba extracts in the guinea pig. |
1986 |
Prostaglandins |
pmid:3763943
|
Guinot P et al. |
Inhibition of PAF-acether induced weal and flare reaction in man by a specific PAF antagonist. |
1986 |
Prostaglandins |
pmid:3763944
|
Scherf H et al. |
Hemodynamic effects of platelet activating factor in the dog kidney in vivo. |
1986 |
Hypertension |
pmid:3744467
|
Schleimer RP et al. |
Characterization of inflammatory mediator release from purified human lung mast cells. |
1986 |
Am. Rev. Respir. Dis. |
pmid:3485946
|
Herrmann DB et al. |
Ether phospholipids as inhibitors of the arachidonoyl-CoA: 1-acyl-sn-glycero-3-phosphocholine acyltransferase in macrophages. |
1986 |
Biochim. Biophys. Acta |
pmid:3947667
|
Robertson DN and Smith GM |
CV3988 inhibits in vivo platelet aggregation induced by PAF-acether and collagen. |
1986 |
Eur. J. Pharmacol. |
pmid:3709663
|
Ostermann G et al. |
The role of lipoproteins in the degradation of platelet-activating factor. |
1986 |
Thromb. Res. |
pmid:3798402
|
Bussolino F et al. |
Interleukin 1 stimulates platelet activating factor production in cultured human endothelial cells. |
1986 |
Pharmacol Res Commun |
pmid:3490673
|
Ramesha CS and Pickett WC |
Metabolism of platelet-activating factor by arachidonic acid-depleted rat polymorphonuclear leukocytes. |
1986 |
J. Biol. Chem. |
pmid:3096991
|
Kawaguchi H and Yasuda H |
Platelet-activating factor stimulates prostaglandin synthesis in cultured cells. |
1986 |
Hypertension |
pmid:3081442
|
Morley J and Sanjar S |
Ketotifen and asthma. |
1986 |
N. Z. Med. J. |
pmid:3466080
|
Page CP |
Platelet activating factor, ketotifen and asthma. |
1986 |
N. Z. Med. J. |
pmid:3466093
|
Etienne A et al. |
Antithrombotic activity of BN 50341, a structurally new compound with anticalcic and PAF-antagonistic properties. |
1986 |
Agents Actions Suppl. |
pmid:3468781
|
Zimmerman GA et al. |
Thrombin stimulates neutrophil adherence by an endothelial cell-dependent mechanism: characterization of the response and relationship to platelet-activating factor synthesis. |
1986 |
Ann. N. Y. Acad. Sci. |
pmid:3471149
|
Rainsford KD |
Relative roles of leukotrienes and platelet activating factor in experimentally-induced gastric ulceration. |
1986 |
Pharmacol Res Commun |
pmid:3774846
|
Page CP and Morley J |
Evidence favouring PAF rather than leukotrienes in the pathogenesis of asthma. |
1986 |
Pharmacol Res Commun |
pmid:3774847
|
Haye-Legrand I et al. |
Production of PAF-acether and leukotrienes by cultured mouse macrophages. |
1986 |
Pharmacol Res Commun |
pmid:3774848
|
Dupont L et al. |
Crystal and molecular structure of BN 52021, a PAF-acether antagonist. Comparison with the conformation of Kadsurenone and related compounds. |
1986 |
Pharmacol Res Commun |
pmid:3774849
|
Bruynzeel PL et al. |
Platelet-activating factor (PAF-acether) induced leukotriene C4 formation and luminol dependent chemiluminescence by human eosinophils. |
1986 |
Pharmacol Res Commun |
pmid:3774850
|
Etienne A et al. |
The relative role of PAF-acether and icosanoids in septic shock. |
1986 |
Pharmacol Res Commun |
pmid:3774851
|